Nuvalent (NUVL) Cash & Equivalents (2020 - 2026)

Nuvalent (NUVL) has 7 years of Cash & Equivalents data on file, last reported at $159.7 million in Q1 2026.

• Quarterly Cash & Equivalents rose 32.19% year-over-year to $159.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $159.7 million (up 32.19% YoY) and the FY2025 annual result came in at $261.7 million, up 79.66% from the prior year.
• Cash & Equivalents declined to $159.7 million in Q1 2026, from $261.7 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $369.2 million in Q3 2024 to a low of $67.3 million in Q1 2022.
• A 5-year average of $158.0 million and a median of $120.8 million in 2025 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2024 — Cash & Equivalents surged 317.54% — and 2025, when it tumbled 68.65%.
• Tracing NUVL's Cash & Equivalents over 5 years: stood at $241.8 million in 2022, then surged by 38.7% to $335.4 million in 2023, then plunged by 56.56% to $145.7 million in 2024, then surged by 79.66% to $261.7 million in 2025, then tumbled by 38.97% to $159.7 million in 2026.
• The last three Cash & Equivalents figures came in at $159.7 million (Q1 2026), $261.7 million (Q4 2025), and $115.8 million (Q3 2025), per Business Quant data.